Caladrius Biosciences, Inc. 4
4 · Caladrius Biosciences, Inc. · Filed Sep 30, 2016
Insider Transaction Report
Form 4
Preti Robert A
See Remarks
Transactions
- Award
Stock Option
2016-09-29+20,894→ 20,894 totalExercise: $4.77From: 2016-09-29Exp: 2026-09-29→ Common Stock (20,894 underlying)
Footnotes (1)
- [F1]These stock options were granted upon the Company's Compensation Committee approval on September 29, 2016, in consideration of the unpaid portion of the reporting person's discretionary 2015 target bonus.